@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-VF9Z2S34-D
  skos:prefLabel "Bétaméthasone"@fr, "Betamethasone"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-N1VZRXD7-9 .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-QXMWV8XK-3
  skos:prefLabel "Glucocorticoids"@en, "Glucocorticoïdes"@fr ;
  a mesh:Descriptor, skos:Concept .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-G4R176S9-J
  skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-N1VZRXD7-9
  mesh:allowableQualifier jvr:-SBNWSM1T-R, jvr:-BT300B3G-Q, jvr:-HQRFT0C6-B, jvr:-CB30NGKB-3, jvr:-S0CS1X5R-5, jvr:-W6SQV79N-S, jvr:-WK5F724J-1, jvr:-D0F21513-5, jvr:-R3QWLHRG-V, jvr:-XV06LPML-W, jvr:-NHL3D2X0-S, jvr:-L6C0XPHT-4, jvr:-THHNVC7V-3, jvr:-R0ZCQ8X6-J, jvr:-NB0XHT3S-N, jvr:-G4R176S9-J, jvr:-G30ZJ446-J, jvr:-M63HSDM7-1, jvr:-H7K65Q8S-Z, jvr:-T9HQD7ST-J, jvr:-Q3979798-W, jvr:-FWD2BGQ0-9, jvr:-NKM836P1-M, jvr:-NFTHND7Q-8, jvr:-TJHVZCRZ-0 ;
  skos:hiddenLabel "Temovate"@en, "Cormax"@en, "Dermovate"@en, "Clobetasol 17-Propionate"@en, "Clobex"@en, "Clobetasol Propionate"@en, "OLUX"@en, "Embeline E"@en, "Embeline"@en ;
  skos:prefLabel "Clobetasol"@en, "Clobétasol"@fr ;
  skos:definition "A derivative of PREDNISOLONE with high glucocorticoid activity and low mineralocorticoid activity. Absorbed through the skin faster than FLUOCINONIDE, it is used topically in treatment of PSORIASIS but may cause marked adrenocortical suppression. This is the form in trademark preparations."@en ;
  skos:altLabel "ADN79D536H"@fr, "ADN79D536H"@en, "25122-41-2 (Clobetasol)"@fr, "25122-41-2 (Clobetasol)"@en, "779619577M"@en, "779619577M"@fr, "Pregna-1,4-diene-3,20-dione, 21-chloro-9-fluoro-11,17-dihydroxy-16-methyl-, (11beta,16beta)-"@fr, "Pregna-1,4-diene-3,20-dione, 21-chloro-9-fluoro-11,17-dihydroxy-16-methyl-, (11beta,16beta)-"@en, "Clofenazon"@en, "25122-46-7 (Clobetasol Propionate)"@en, "25122-46-7 (Clobetasol Propionate)"@fr ;
  dc:created "1976-04-13"^^xsd:date ;
  mesh:pharmacologicalAction jvr:-QXMWV8XK-3, jvr:-FW3F2V3X-Z ;
  dc:modified "2016-05-28"^^xsd:date ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D002990> ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-VF9Z2S34-D ;
  skos:inScheme jvr: ;
  dc:established "1991-01-01"^^xsd:date .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-FW3F2V3X-Z
  skos:prefLabel "Anti-inflammatoires"@fr, "Anti-Inflammatory Agents"@en ;
  a mesh:Descriptor, skos:Concept .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .